Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis

Kidney International

Volumn 43, Issue 2, 1993, Pages 369-380

  Floege, Jürgen ^a   Eng, Eudora ^a   Young, Bessie A ^a   Couser, William G ^a   Johnson, Richard J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CELL DIVISION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTOR 2; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEPARIN; MALE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, WISTAR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027279025     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1993.55     Document Type: Article

References (65)

1. BORDER WA: Distinguishing minimal-change disease from mesangial disorders. Kidney Int 34:419-430, 1988
2. ALPERS CE, HUDKINS KL, GOWN AM, JOHNSON RJ: Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (in press)
3. FLOEGE J, JOHNSON RJ, GORDON K, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
4. PESCE CM, STRIKER LJ, PETEN E, ELLIOT S, STRIKER GE: Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605, 1991
5. DOI T, STRIKER LJ, KIMATA K, PETEN EP, YAMADA Y, STRIKER GE: Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 173:1287-1290, 1991
6. FLOEGE J, BURNS MW, ALPERS CE, YOSHIMURA A, PRITZL P, GORDON K, SEIFERT RA, BOWEN-POPE DF, COUSER WG, JOHNSON RJ: Glomerular cell proliferation and PDGF expression precedes glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
7. FLOEGE J, ALPERS CE, BURNS MW, PRITZL P, GORDON K, COUSER WG, JOHNSON RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest (in press)
8. RENNKE HG: Structural alterations associated with glomerular hyperfiltration, in The Progressive Nature of Renal Disease, edited by MITCH WE, BRENNER BM, STEIN JH, New York, Churchill Livingstone, 1986, pp. 111-131
9. STRIKER LJ, PETEN EP, ELLIOT SJ, DOI T, STRIKER GE: Mesangial cell turnover effect of heparin and peptide growth factors. Lab Invest 64:446-456, 1991
10. CASTELLOT JJ, HOOVER RL, HARPER PA, KARNOVSKY MJ: Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial cell proliferation. Am J Pathol 120:427-435, 1985
11. CASTELLOT JJ, HOOVER RL, KARNOVSKY MJ: Glomerular endothelial cells secrete a heparin-like inhibitor and a peptide stimulator of mesangial cell proliferation. Am J Pathol 125:493-500, 1986
12. GROGGEL GC, MARINIDES GN, HOVINGH P, HAMMOND E, LINKER A: Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol 258:F259-F265, 1990
13. COFFEY AK, KARNOVSKY MJ: Heparin inhibits mesangial cell proliferation in Habu-venom-induced glomerular injury. Am J Pathol 120:248-255, 1985
14. DIAMOND JR, KARNOVSKY MJ: Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol 9:366-374, 1986
15. NAPARSTEK Y, BEN-YEHUDA A, MADAIO MP, BAR-TANA R, SCHUGER L, PIZOV G, NEEMAN Z, COHEN IR: Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/ lpr mice by heparin. Arthrit Rheum 33:1554-1559, 1990
16. DOHI K, FUJIOKA M, NAKAMOTO Y: Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis. Acta Pathol Jpn 32:1047-1052, 1982
17. YAMAMOTO T, WILSON CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 32:514-525, 1987
18. BACCHUS WM, HOEDEMAEKER PJ, ROZING J, BAKKER WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. Lab Invest 55:680-687, 1986
19. JOHNSON RJ, GARCIA RL, PRITZL P, ALPERS CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136:369- 374, 1990
20. YAMAMOTO T, YAMAMOTO K, KAWASAKI K, YAOITA E, SHIMIZU F, KIHARA I: Immunoelectron microscopic demonstration of Thy-1 antigen on the surface of mesangial cells in the rat glomerulus. Nephron 43:293-298, 1986
21. JOHNSON RJ, IIDA H, ALPERS CE, MAJESKY MW, SCHWARTZ SM, PRITZL P, GORDON K, GOWN AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87:847-858, 1991
22. KURKI P, VANDERLAAN M, DOLBEARE F, GRAY J, TAN EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-219, 1986
23. SKALLI O, ROPRAZ P, TRZECIAK A, BENZONANA G, GILLESSEN D, GABBIANI G: A monoclonal antibody against α-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 103:2787-2796, 1986
24. SHIRAISHI T, MORIMOTO S, ITOH K, SATO H, SUGIHARA K, ONISHI T, OGIHARA T: Radioimmunoassay of human platelet-derived growth factor using monoclonal antibodies toward a synthetic 73-97 fragment of its B-chain. Clin Chim Acta 184:65-74, 1989
25. IIDA H, SEIFERT R, ALPERS CE, GRONWALD RGK, PHILIPS PE, PRITZL P, GORDON K, GOWN AM, ROSS R, BOWEN-POPE DF, JOHNSON RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 88:6560-6564, 1991
26. REILLY TM, TAYLOR DS, HERBLIN WF, THOOLEN MJ, CHIU AT, WATSON DW, TIMMERMANS PBMWM: Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem Biophys Res Commun 2:736-743, 1989
27. 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. J Biol Chem 266:18345-18351, 1991
28. BIEBER F: Biotinylierung monoklonaler Antikörper, in Monoklonale Antikörper. Herstellung und Charakterisierung, edited by PETERS H, Berlin, Springer, 1985, pp. 209-212
29. COUCHMAN JR: Heterogeneous distribution of a basement membrane heparan sulfate proteoglycan in rat tissues. J Cell Biol 105:1901-1916, 1987
30. CARLIN B, JAFFE R, BENDER B, CHUNG AE: Entactin, a novel basal lamina-associated sulfated glycoprotein. J Biol Chem 256:5209-5214, 1981
31. BACCHUS WM, JEUNINK MF, ROZING J, ELEMA JD: A monoclonal antibody against rat platelets. I. Tissue distribution in vitro and in vivo. Clin Exp Immunol 75:317-323, 1989
32. WALLENSTEIN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
33. JOHNSON RJ, PRITZL P, IIDA H, ALPERS CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313-321, 1991
34. FLOEGE J, ENG E, LINDNER V, YOUNG BA, REIDY MA, JOHNSON RJ: Rat glomerular mesangial cells synthesize basic FGF: Release, upregulated synthesis and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest (in press)
35. BACCHUS WM, JEUNINK MF, ELEMA JD: The mesangium in anti-Thy-1 nephritis. Am J Pathol 137:215-222, 1990
36. TANG WW, WILSON CB: Effects of anticoagulant heparin on antibody-induced mesangial hypercellularity and focal mesangial matrix increase, (abstract) Kidney Int 37:434, 1990
37. BACCHUS WM, JEUNIK MF, ELEMA JD: Effects of platelets and heparin on rat mesangial cell proliferation in vivo. (abstract) Kidney Int 36:510, 1989
38. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SCHWARTZ SM: Renal injury from angiotensin-II mediated hypertension. Hypertension 19:464-474, 1992
39. POELSTRA K, HARDONK MJ, KOUDSTAAL J, BARKER WW: Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 37:1500-1508, 1990
40. BALLERMANN BJ: Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 256:C182-C189, 1989
41. ADLER S: Inhibition of rat glomerular visceral epithelial cell growth by heparin. Am J Physiol 255:F781-F786, 1988
42. PURKERSON ML, TOLLEFSEN DM, KLAHR S: N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 81:69-74, 1988
43. SCHLÖNDORFF D: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1:272-281, 1987
44. MENÈ P, SIMONSON MS, DUNN MJ: Physiology of the mesangial cell. Physiol Rev 69:1347-1424, 1989
45. CASTELLOT JJ, PUKAC LA, CALEB BL, WRIGHT TC, KARNOVSKY MJ: Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol 109:3147-3152, 1989
46. REILLY CF, KINDY MS, BROWN KE, ROSENBERC RD, SONENSHEIN GE: Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle. J Biol Chem 264:6990-6996, 1989
47. JOHNSON RJ, RAINES E, FLOEGE J, YOSHIMURA A, PRITZL P, ALPERS C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet derived growth factor. J Exp Med 175:1413-1416, 1992
48. LIMANNI A, FLEMING T, MOLINA R, HUFNAGEL H, CUNNINGHAM RE, CRUESS DF, SHAREFKIN JB: Expression of genes for platelet-derived growth factor in adult human venous endothelium. J Vasc Surg 7:10-20, 1988
49. POGGI A, RUCINSKI B, JAMES P, HOLT JC, NIEWIAROWSKI S: Partial purification and characterization of porcine platelet-derived growth factor. Exp Cell Res 150:436-441, 1984
50. CAMUSSI G, TETTA C, MAZZUCCO G, MONGA G, ROFFINELLO C, ALBERTON M, DELLABONA P, MALAVASI F, VERCELLONE A: Platelet cationic proteins are present in glomeruli of lupus nephritis patients. Kidney Int 30:555-565, 1986
51. UHLRICH S, LAGENTE O, LENFANT M, COURTOIS Y: Effect of heparin on the stimulation of non-vascular cells by human acidic and basic FGF. Biochem Biophys Res Commun 137:1205-1213, 1986
52. GOSPODAROWICZ D, CHENG J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484, 1986
53. THOMPSON RW, WHALEN GF, SAUNDERS KB, HORES T, D'AMORE PA: Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits. Growth Factors 3:221-229, 1990
54. BASHKIN P, DOCTROW S, KLAGSBRUN M, SVAHN CM, FOLKMAN J, VLODAVSKY I: Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28:1737-1743, 1989
55. PERSON JM, LOVETT DH, RAUGI GJ: Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparinlike glycosaminoglycans. Am J Pathol 133:609-614, 1988
56. CLOWES AW, CLOWES MM: Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 58:839-845, 1986
57. ICHIKAWA I, YOSHIDA Y, FOGO A, PURKERSON ML, KLAHR S: Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int 34:638-644, 1988
58. OLSON JL: Role of heparin as a protective agent following reduction of renal mass. Kidney Int 25:376-382, 1984
59. CADE JR, DEQUESADA AM, SHIRES DL, LEVIN DM, HACKETT RL, SPOONER GR, SCHLEIN EM, PICKERING MJ, HOLCOMB A: The effect of long-term high dose heparin treatment on the course of chronic proliferative glomerulonephritis. Nephron 8:67-80, 1971
60. KINCAID-SMITH P: Coagulation and renal disease. Kidney Int 2:183-190, 1972
61. HOMMA T, BROADLEY C, HOOVER RL, ICHIKAWA I, HARRIS RC: Heparin reduces synthesis of collagenous proteins in rat glomerular mesangial cells. (abstract) Kidney Int 37:508, 1990
62. LYONS-GIORDANO B, CONAWAY H, KEFALIDES NA: The effect of heparin on fibronectin and thrombospondin synthesis by human smooth muscle cells. Biochem Biophys Res Commun 148:1264-1270, 1987
63. SNOW AD, BOLENDER RP, WIGHT TN, CLOWES AW: Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 137:313-321, 1990
64. NADER HB, BUONASSISI V, COLBURN P, DIETRICH CP: Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J Cell Physiol 140:305-313, 1989
65. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. (letter) Nature 346:371-374, 1990